|73.15||-1.69||-2.26%||Vol 330.90K||1Y Perf -25.19%|
|Jun 28th, 2022 16:00 DELAYED|
|- -||- -%|
|Target Price||90.67||Analyst Rating||Strong Buy 1.00|
|Potential %||23.95||Finscreener Ranking||★★★+ 51.41|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★★+ 52.58|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★★+ 63.72|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||★★★★+ 54.14|
|Price Range Ratio 52W %||11.32||Earnings Rating||Strong Sell|
|Market Cap||7.38B||Earnings Date||4th Aug 2022|
Today's Price Range
5 Year PE Ratio Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||4th Aug 2022|
|Estimated EPS Next Report||0.40|
|EPS Growth Next 5 Years %||16.00|
|Avg. Weekly Volume||435.36K|
|Avg. Monthly Volume||444.47K|
|Avg. Quarterly Volume||480.88K|
Dolby Laboratories (NYSE: DLB) stock closed at 74.84 per share at the end of the most recent trading day (a -1.53% change compared to the prior day closing price) with a volume of 306.23K shares and market capitalization of 7.38B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Software industry, Technology sector and employs 2289 people. Dolby Laboratories CEO is Kevin J. Yeaman.
The one-year performance of Dolby Laboratories stock is -25.19%, while year-to-date (YTD) performance is -21.4%. DLB stock has a five-year performance of 49.68%. Its 52-week range is between 69.18 and 104.25, which gives DLB stock a 52-week price range ratio of 11.32%
Dolby Laboratories currently has a PE ratio of 36.50, a price-to-book (PB) ratio of 2.95, a price-to-sale (PS) ratio of 3.86, a price to cashflow ratio of 21.00, a PEG ratio of 2.32, a ROA of 7.19%, a ROC of 7.99% and a ROE of 8.55%. The company’s profit margin is 17.25%, its EBITDA margin is 27.70%, and its revenue ttm is $1.26 Billion , which makes it $19.41 revenue per share.
Of the last four earnings reports from Dolby Laboratories, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.40 for the next earnings report. Dolby Laboratories’s next earnings report date is 04th Aug 2022.
The consensus rating of Wall Street analysts for Dolby Laboratories is Strong Buy (1), with a target price of $90.67, which is +23.95% compared to the current price. The earnings rating for Dolby Laboratories stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Dolby Laboratories has a dividend yield of 1.34% with a dividend per share of $1.00 and a payout ratio of 29.00%.
Dolby Laboratories has a Neutral technical analysis rating based on Technical Indicators (ADX : 8.31, ATR14 : 1.78, CCI20 : 9.50, Chaikin Money Flow : -0.13, MACD : -0.68, Money Flow Index : 38.78, ROC : -2.93, RSI : 51.49, STOCH (14,3) : 59.48, STOCH RSI : 0.83, UO : 52.28, Williams %R : -40.52), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Dolby Laboratories in the last 12-months were: Andy Sherman (Sold 5 099 shares of value $437 362 ), Avadis Tevanian (Sold 1 331 shares of value $100 238 ), John D. Couling (Sold 1 772 shares of value $130 965 ), Kevin J. Yeaman (Option Excercise at a value of $8 281 801), Kevin J. Yeaman (Sold 222 392 shares of value $20 685 568 ), Lewis Chew (Option Excercise at a value of $4 438 650), Lewis Chew (Sold 125 000 shares of value $12 315 349 ), Ryan Nicholson (Option Excercise at a value of $88 421), Ryan Nicholson (Sold 3 264 shares of value $329 842 ), Steve Forshay (Option Excercise at a value of $1 570 224), Steve Forshay (Sold 26 863 shares of value $2 720 002 ), Todd Pendleton (Option Excercise at a value of $1 627 663), Todd Pendleton (Sold 28 156 shares of value $2 787 300 )
Wed, 16 Mar 2022 17:35 GMT Analysts Are Bullish on These Technology Stocks: TPG Telecom Limited (TPGTF), Dolby Laboratories (DLB)- TipRanks. All rights reserved.
Sat, 12 Feb 2022 09:12 GMT Dolby Laboratories (DLB) Gets a Buy Rating from J.P. Morgan- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro. Your capital is at risk.
This could take some time, please wait.